FDA Adverse Event Injury Summary report: N

WAVEWRITER ALPHA 16

MDR report key: 13148982 · Received January 4, 2022

Report

Report Number
3006630150-2021-07442
Event Type
Injury
Date Received
January 4, 2022
Date of Event
October 25, 2021
Report Date
February 8, 2022
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729985082
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT: EXACT DATE UNKNOWN, EVENT OCCURRED A WEEK AFTER IMPLANT. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS, UPN: M365SC2352500, MODEL: SC-2352-50, SERIAL: (B)(4), BATCH: 7070617 / 7073268.

Description of Event or Problem · 0

IT WAS REPORTED THAT A WEEK FOLLOWING IMPLANT, THE PATIENT DEVELOPED AN INFECTION ACROSS BOTH IPG AND LEAD INCISION SITES. SYMPTOMS OF REDNESS, WARM TO TOUCH AND SORENESS WERE NOTED. THE INFECTION WAS NOT DEVICE OR PROCEDURE RELATED AND THE CAUSE WAS UNKNOWN. THE PATIENT WAS PRESCRIBED ANTIBIOTICS, TREATED AND CLEARED OF INFECTION.

Description of Event or Problem · 0

IT WAS REPORTED THAT A WEEK FOLLOWING IMPLANT, THE PATIENT DEVELOPED AN INFECTION ACROSS BOTH IPG AND LEAD INCISION SITES. SYMPTOMS OF REDNESS, WARM TO TOUCH AND SORENESS WERE NOTED. THE INFECTION WAS NOT DEVICE OR PROCEDURE RELATED AND THE CAUSE WAS UNKNOWN. THE PATIENT WAS PRESCRIBED ANTIBIOTICS, TREATED AND CLEARED OF INFECTION. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT UNDERWENT A SPINAL CORD STIMULATOR (SCS) SYSTEM EXPLANT PROCEDURE. THE EXPLANTED IPG AND LEADS WERE NOT RETURNED AS THEY WERE KEPT BY THE MEDICAL FACILITY. THE PATIENT WAS DOING WELL POST-OPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
706725 WAVEWRITER ALPHA 16 STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-1216 522991 08714729985082

Patients

Seq Age Sex Outcome Treatment
1 70 YR Male Required Intervention